Early Single-Center Experience With Irreversible Electroporation for Stage 2, 3, and 4 Pancreatic Adenocarcinomas
Christopher J Wall(Royal University Hospital), Mike Moser(Roswell Park Comprehensive Cancer Center), Maurice Ogaick(University of Saskatchewan), Haji Chalchal, Trustin Domes(University of Saskatchewan), Yigang Luo(University of Saskatchewan), Gavin Beck(University of Saskatchewan), John M. Shaw(University of Saskatchewan), Rasel Kabir(University of Saskatchewan), Hyun J. Lim(University of Saskatchewan), Mussawar Iqbal(University of Saskatchewan), Shahid Ahmed(Emory University)
Cited by 1
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Diffuse axonal injury in children: Clinical correlation with hemorrhagic lesions
|Annals of Neurology|2004|344
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
A Randomized Clinical Trial of Granulocyte Transfusions for Infection in Acute Leukemia
|New England Journal of Medicine|1977|299